Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia

Yunju Ma; Changju Qu; Haiping Dai; Jia Yin; Zheng Li; Jia Chen; Huiying Qiu; Aining Sun; Miao Miao; Chengcheng Fu; Zhengming Jin; Xiaming Zhu; Depei Wu; Xiaowen Tang

doi:10.1038/s41409-019-0677-z

Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia

Bone Marrow Transplant. 2020 Jun;55(6):1206-1208. doi: 10.1038/s41409-019-0677-z. Epub 2019 Sep 18.

Authors

Yunju Ma^{1

2

3

4}, Changju Qu^{1

2

3

4}, Haiping Dai^{1

2

3

4}, Jia Yin^{1

2

3

4}, Zheng Li^{1

2

3

4}, Jia Chen^{1

2

3

4}, Huiying Qiu^{1

2

3

4}, Aining Sun^{1

2

3

4}, Miao Miao^{1

2

3

4}, Chengcheng Fu^{1

2

3

4}, Zhengming Jin^{1

2

3

4}, Xiaming Zhu^{1

2

3

4}, Depei Wu^{5

6

7

8}, Xiaowen Tang^{9

10

11

12}

Affiliations

¹ Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, 188 Shizi Road, 215006, Suzhou, China.
² Institute of Blood and Marrow Transplantation, 215006, Suzhou, China.
³ Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
⁴ Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
⁵ Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, 188 Shizi Road, 215006, Suzhou, China. [email protected].
⁶ Institute of Blood and Marrow Transplantation, 215006, Suzhou, China. [email protected].
⁷ Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. [email protected].
⁸ Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China. [email protected].
⁹ Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, 188 Shizi Road, 215006, Suzhou, China. [email protected].
¹⁰ Institute of Blood and Marrow Transplantation, 215006, Suzhou, China. [email protected].
¹¹ Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. [email protected].
¹² Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China. [email protected].

PMID: 31534194
DOI: 10.1038/s41409-019-0677-z

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Decitabine / therapeutic use
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute* / therapy
Recurrence
Transplantation, Homologous

Substances

Decitabine